Regulation of endothelin-converting enzyme-1 (ECE-1) by the calcimimetic R-568-Reference-Cited by-同舟云学术

Regulation of endothelin-converting enzyme-1 (ECE-1) by the calcimimetic R-568

Published:2013-10 Issue: Volume:76 Page:106-118
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Martínez-Miguel Patricia,Medrano-Andrés Diana,Lopes-Martín Vanessa,Arribas-Gómez Ignacio,Rodríguez-Puyol Manuel,Rodríguez-Puyol Diego,López-Ongil Susana

Funder

AMGEN

Publisher

Elsevier BV

Subject

Pharmacology

Reference54 articles.

1. Mechanisms of secondary hyperparathyroidism;Silver;Am J Physiol Renal Physiol,2002

2. Vitamin D receptor activator selectively in the treatment of secondary hyperparathyroidism: understanding the differences among therapies;Brancaccio;Drugs,2007

3. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism;Cunningham;Kidney Int,2005

4. Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients;Block;Kidney Int,2010

5. Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors;Ogata;J Am Soc Nephrol,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The calcimimetic R-568 attenuates subarachnoid hemorrhage-induced vasospasm through PI3K/Akt/eNOS signaling pathway in the rat model;Brain Research;2021-08

2. Unfavorable Reduction in the Ratio of Endothelin B to A Receptors in Experimental 5/6 Nephrectomy and Adenine Models of Chronic Renal Insufficiency;International Journal of Molecular Sciences;2020-01-31

3. Atherosclerosis in Chronic Kidney Disease;Arteriosclerosis, Thrombosis, and Vascular Biology;2019-10

4. Tweak up-regulates endothelin-1 system in mouse and human endothelial cells;Cardiovascular Research;2016-12-25

5. The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial;Journal of Human Hypertension;2015-06-04